These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8719487)

  • 1. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
    Rabinovitch M; Molossi S; Clausell N
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of graft vascular disease: implications of vascular remodeling.
    Gibbons GH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.
    Aziz S; McDonald TO; Gohra H
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S246-9. PubMed ID: 8719495
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury.
    Day JD; Rayburn BK; Gaudin PB; Baldwin WM; Lowenstein CJ; Kasper EK; Baughman KL; Baumgartner WA; Hutchins GM; Hruban RH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S142-9. PubMed ID: 8719476
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen immunostaining of the endothelial cells in lung transplantation.
    Barberis M; Harari S
    Transplant Proc; 1992 Dec; 24(6):2667-9. PubMed ID: 1361264
    [No Abstract]   [Full Text] [Related]  

  • 10. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP
    J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant vascular disease: role of lipids and proteoglycans.
    Rahmani M; McDonald PC; Wong BW; McManus BM
    Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of cardiac allograft vasculopathy.
    Dong C; Redenbach D; Wood S; Battistini B; Wilson JE; McManus BM
    Curr Opin Cardiol; 1996 Mar; 11(2):183-90. PubMed ID: 8736690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.
    Martí V; Romeo I; Aymat R; García J; Guiteras P; Ballester M; Aminian N; Caralps JM; Augé JM
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1174-80. PubMed ID: 11726893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy.
    Hosenpud JD; Everett JP; Morris TE; Wagner CR; Shipley GD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S185-7. PubMed ID: 8719483
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
    Esper E; Glagov S; Karp RB; Simonsen KK; Filer SR; Scanu AM; Sand ME
    J Heart Lung Transplant; 1997 Apr; 16(4):420-35. PubMed ID: 9154953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the diagnosis and management of cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
    Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group.
    Yeung AC; Davis SF; Hauptman PJ; Kobashigawa JA; Miller LW; Valantine HA; Ventura HO; Wiedermann J; Wilensky R
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S215-20. PubMed ID: 8719489
    [No Abstract]   [Full Text] [Related]  

  • 20. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.